APO LXR 500 Pill - white oval, 17mm
Pill with imprint APO LXR 500 is White, Oval and has been identified as Levetiracetam Extended Release 500 mg. It is supplied by Apotex Corp.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LXR 500







Levetiracetam Extended Release
- Imprint
- APO LXR 500
- Strength
- 500 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
hypromellose 2208 (15000 mPa.s),
silicon dioxide,
hypromellose 2910 (5 mPa.s),
hydroxypropyl cellulose,
polyethylene glycol 8000,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
60505-3280 | Apotex Corp. |
60429-0349 | Golden State Medical Supply (repackager) |
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (426)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Injection
- Levetiracetam Tablets
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.